{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T05:58:36Z","timestamp":1695275916813},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,5,6]],"date-time":"2012-05-06T00:00:00Z","timestamp":1336262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s12032-012-0248-2","type":"journal-article","created":{"date-parts":[[2012,5,5]],"date-time":"2012-05-05T12:59:44Z","timestamp":1336222784000},"page":"3529-3534","source":"Crossref","is-referenced-by-count":3,"title":["Plasmablastic lymphoma of the retroperitoneum in an HIV- and HCV-positive patient: hard to diagnose and harder to treat"],"prefix":"10.1007","volume":"29","author":[{"given":"Bhagirathbhai","family":"Dholaria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisy","family":"Alapat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarun","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,6]]},"reference":[{"issue":"1","key":"248_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-004-0939-7","volume":"84","author":"AM Muller","year":"2005","unstructured":"Muller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin\u2019s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005;84(1):1\u201312. doi: 10.1007\/s00277-004-0939-7 .","journal-title":"Ann Hematol"},{"key":"248_CR2","unstructured":"SEER Cancer Statistics Review, 1975\u20132008, National Cancer Institute. Bethesda, MD [database on the Internet]1975\u20132008. Available from: http:\/\/seer.cancer.gov\/csr\/1975_2008\/ . Accessed 22 Dec 2011."},{"issue":"1","key":"248_CR3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/000348949910800115","volume":"108","author":"A Carbone","year":"1999","unstructured":"Carbone A, Gaidano G, Gloghini A, Ferlito A, Rinaldo A, Stein H. AIDS-related plasmablastic lymphomas of the oral cavity and jaws: a diagnostic dilemma. Ann Otol Rhinol Laryngol. 1999;108(1):95\u20139.","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"5","key":"248_CR4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11912-005-0062-5","volume":"7","author":"J Teruya-Feldstein","year":"2005","unstructured":"Teruya-Feldstein J. Diffuse large B-cell lymphomas with plasmablastic differentiation. Curr Oncol Rep. 2005;7(5):357\u201363.","journal-title":"Curr Oncol Rep"},{"issue":"10","key":"248_CR5","first-page":"1","volume":"83","author":"AG Antonino Carbone","year":"2008","unstructured":"Antonino Carbone AG. Plasmablastic lymphoma: one or more entities? Am J Hematol. 2008;83(10):1.","journal-title":"Am J Hematol"},{"issue":"10","key":"248_CR6","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ajh.21250","volume":"83","author":"J Castillo","year":"2008","unstructured":"Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol. 2008;83(10):804\u20139. doi: 10.1002\/ajh.21250 .","journal-title":"Am J Hematol"},{"issue":"11","key":"248_CR7","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3109\/10428194.2010.516040","volume":"51","author":"JJ Castillo","year":"2010","unstructured":"Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, et al. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma. 2010;51(11):2047\u201353. doi: 10.3109\/10428194.2010.516040 .","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"248_CR8","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1440-1827.2009.02457.x","volume":"59","author":"Y Takahashi","year":"2009","unstructured":"Takahashi Y, Saiga I, Fukushima J, Seki N, Sugimoto N, Hori A, et al. Plasmablastic lymphoma of the retroperitoneum in an HIV-negative patient. Pathol Int. 2009;59(12):868\u201373. doi: 10.1111\/j.1440-1827.2009.02457.x .","journal-title":"Pathol Int"},{"issue":"11","key":"248_CR9","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","volume":"34","author":"A Valera","year":"2010","unstructured":"Valera A, Balague O, Colomo L, Martinez A, Delabie J, Taddesse-Heath L, et al. IG\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol. 2010;34(11):1686\u201394. doi: 10.1097\/PAS.0b013e3181f3e29f .","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"248_CR10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/modpathol.2010.72","volume":"23","author":"L Taddesse-Heath","year":"2010","unstructured":"Taddesse-Heath L, Meloni-Ehrig A, Scheerle J, Kelly JC, Jaffe ES. Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features. Mod Pathol. 2010;23(7):991\u20139. doi: 10.1038\/modpathol.2010.72 .","journal-title":"Mod Pathol"},{"issue":"6","key":"248_CR11","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood-2008-09-180315","volume":"113","author":"A Carbone","year":"2009","unstructured":"Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF. HIV-associated lymphomas and gamma-herpesviruses. Blood. 2009;113(6):1213\u201324. doi: 10.1182\/blood-2008-09-180315 .","journal-title":"Blood"},{"issue":"1","key":"248_CR12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yexmp.2010.10.007","volume":"90","author":"X Qing","year":"2011","unstructured":"Qing X, Sun N, Chang E, French S, Ji P, Yue C. Plasmablastic lymphoma may occur as a high-grade transformation from plasmacytoma. Exp Mol Pathol. 2011;90(1):85\u201390. doi: 10.1016\/j.yexmp.2010.10.007 .","journal-title":"Exp Mol Pathol"},{"issue":"2","key":"248_CR13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2169\/internalmedicine.39.112","volume":"39","author":"F Mizorogi","year":"2000","unstructured":"Mizorogi F, Hiramoto J, Nozato A, Takekuma Y, Nagayama K, Tanaka T, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin\u2019s lymphoma. Intern Med. 2000;39(2):112\u20137.","journal-title":"Intern Med"},{"key":"248_CR14","doi-asserted-by":"crossref","unstructured":"Machida K, Tsukiyama-Kohara K, Sekiguch S, Seike E, Tone S, Hayashi Y, et al. Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins. Gastroenterology. 2009;137(1):285\u201396, 96 e1\u201311. doi: 10.1053\/j.gastro.2009.03.061 .","DOI":"10.1053\/j.gastro.2009.03.061"},{"issue":"8","key":"248_CR15","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3324\/haematol.2009.016113","volume":"95","author":"S Montes-Moreno","year":"2010","unstructured":"Montes-Moreno S, Gonzalez-Medina AR, Rodriguez-Pinilla SM, Maestre L, Sanchez-Verde L, Roncador G, et al. Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype. Haematologica. 2010;95(8):1342\u20139. doi: 10.3324\/haematol.2009.016113 .","journal-title":"Haematologica"},{"issue":"1","key":"248_CR16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1182\/blood-2007-06-094151","volume":"111","author":"S Montes-Moreno","year":"2008","unstructured":"Montes-Moreno S, Roncador G, Maestre L, Martinez N, Sanchez-Verde L, Camacho FI, et al. Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas. Blood. 2008;111(1):351\u20138. doi: 10.1182\/blood-2007-06-094151 .","journal-title":"Blood"},{"issue":"6","key":"248_CR17","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/modpathol.3800355","volume":"18","author":"F Vega","year":"2005","unstructured":"Vega F, Chang CC, Medeiros LJ, Udden MM, Cho-Vega JH, Lau CC, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol. 2005;18(6):806\u201315. doi: 10.1038\/modpathol.3800355 .","journal-title":"Mod Pathol"},{"issue":"4","key":"248_CR18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5045\/kjh.2010.45.4.223","volume":"45","author":"Q Choi","year":"2010","unstructured":"Choi Q, Kim HK. Plasmablastic plasma cell myeloma mimicking plasmablastic lymphoma. Korean J Hematol. 2010;45(4):223. doi: 10.5045\/kjh.2010.45.4.223 .","journal-title":"Korean J Hematol"},{"issue":"3","key":"248_CR19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1634\/theoncologist.2009-0304","volume":"15","author":"JJ Castillo","year":"2010","unstructured":"Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, et al. Prognostic factors in chemotherapy-treated patients with HIV-associated plasmablastic lymphoma. Oncologist. 2010;15(3):293\u20139. doi: 10.1634\/theoncologist.2009-0304 .","journal-title":"Oncologist"},{"issue":"1","key":"248_CR20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/sj.leu.2403206","volume":"18","author":"I Simonitsch-Klupp","year":"2004","unstructured":"Simonitsch-Klupp I, Hauser I, Ott G, Drach J, Ackermann J, Kaufmann J, et al. Diffuse large B-cell lymphomas with plasmablastic\/plasmacytoid features are associated with TP53 deletions and poor clinical outcome. Leukemia. 2004;18(1):146\u201355. doi: 10.1038\/sj.leu.2403206 .","journal-title":"Leukemia"},{"key":"248_CR21","unstructured":"NCCN Practice Guidelines in Oncology. Non-Hodgkins lymphomas. national comprehensive cancer network. (2011) http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/nhl.pdf . Accessed 16 Jan 2012."},{"issue":"24","key":"248_CR22","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1182\/blood-2009-01-199679","volume":"113","author":"K Dunleavy","year":"2009","unstructured":"Dunleavy K, Pittaluga S, Czuczman MS, Dave SS, Wright G, Grant N, et al. Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood. 2009;113(24):6069\u201376. doi: 10.1182\/blood-2009-01-199679 .","journal-title":"Blood"},{"issue":"34","key":"248_CR23","doi-asserted-by":"crossref","first-page":"e704","DOI":"10.1200\/JCO.2010.30.0038","volume":"28","author":"M Bibas","year":"2010","unstructured":"Bibas M, Grisetti S, Alba L, Picchi G, Del Nonno F, Antinori A. Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone. J Clin Oncol. 2010;28(34):e704\u20138. doi: 10.1200\/jco.2010.30.0038 .","journal-title":"J Clin Oncol"},{"issue":"6","key":"248_CR24","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1600-0609.2009.01235.x","volume":"82","author":"P Bose","year":"2009","unstructured":"Bose P, Thompson C, Gandhi D, Ghabach B, Ozer H. AIDS-related plasmablastic lymphoma with dramatic, early response to bortezomib. Eur J Haematol. 2009;82(6):490\u20132. doi: 10.1111\/j.1600-0609.2009.01235.x .","journal-title":"Eur J Haematol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-012-0248-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-012-0248-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-012-0248-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T23:43:37Z","timestamp":1642203817000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-012-0248-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,6]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["248"],"URL":"https:\/\/doi.org\/10.1007\/s12032-012-0248-2","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,6]]}}}